Advent to buy majoritystake in ZCL


Advent International, a private equity investor, has signed an agreement to acquire a majority stake in pharmaceutical company ZCL Chemicals Ltd.

With this transaction, Morgan Stanley Private Equity Asia, a private equity platform, will exit its investment.

ZCL (formerly Zandu Chemicals Ltd.) is into manufacture of speciality active pharmaceutical ingredients (APIs) and advanced intermediates.

“ZCL will further fortify our presence in the API market, a key sub-sector focus of ours,” said Shweta Jalan, MD and head of India, Advent International, India.

You have reached your limit for free articles this month.

Subscription Benefits Include

Today’s Paper

Find mobile-friendly version of articles from the day’s newspaper in one easy-to-read list.

Unlimited Access

Enjoy reading as many articles as you wish without any limitations.

Personalised recommendations

A select list of articles that match your interests and tastes.

Faster pages

Move smoothly between articles as our pages load instantly.

Dashboard

A one-stop-shop for seeing the latest updates, and managing your preferences.

Briefing

We brief you on the latest and most important developments, three times a day.

Support Quality Journalism.

*Our Digital Subscription plans do not currently include the e-paper, crossword and print.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *